Recent News

Discovery Life Sciences Acquires AllCells

July 12, 2022
Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, today announced its acquisition of AllCells®  , a leading provider of clinical-grade (GMP-compliant) and Research Use Only (RUO) primary cell products.  With more than ...
Read More
SpecimenSeq Cancer Tissue Samples with Known Mutations

SpecimenSeq Cancer Tissue Samples with Known Mutations

Thousands of tissue samples with full genotyping data make cohort selection a breeze. SpecimenSeq: Saving time, reducing cost, and accelerating research
July 6, 2022
Read More

Hansonwade Webinar | Next Generation Cell Therapies: Combined Analytics & Cryopreserved Starting Materials

June 28, 2022
CGT Industry experts and influencers Dr. Dominic Clarke, Daniel Ciccone, and Philip Eckels speak during a webinar to engage with these experts and gain valuable insights on process development strategies to improve ...
Read More
Visualizing Patterns and Trends Across Cancer Types Using DTCs

Visualizing Patterns and Trends Across Cancer Types Using DTCs

Analyzing thousands of cancer tissue samples in the form of DTCs provides insights into the nature of different cancer indications
June 28, 2022
Read More